Introduction
It is one of the smallest nuclear cell-type micro-organisms that lacks cytowalls, is highly multiform, is able to pass through a filter, and can grow and reproduce in a lifeless culture. Pyrophoric infections can overwhelm several parts of the respiratory and urinary tracts, with varying degrees of impact on the health of patients. Scientificly rational use of Western medicine is essential for effective control of secondary infections, mitigation of symptoms and prevention of complications.
II. Common types of secondary infections and symptoms
(i) Respiratory husk infections
The main pathogen is the pneumonia trimester. Patients often suffer from heat, cough, mostly irritating dry coughs, which can be accompanied by a small amount of sticky adhesive, and serious cases of chest pain and respiratory difficulties. Some of the patients may also have whole-body manifestations of headaches, inefficiency and muscular acid.
(ii) Subgenital infections in the urinary tract
Ethyroids, humans, etc. are common pathogens of urinary tract infections. Men can experience uretitis symptoms after infection, such as frequent, acute and painful urine, as well as mild red and edema in the mouth of the urinal tract, and thin genre. If the infection spreads to the prostate, testics, etc., it causes prostate inflammation, testicitis, vaginal fallout, pain, scrotum pain, etc. Female infections can give rise to uretitis, cervical inflammation, manifested in increased white belts, tasting, larvae itching, uretitis symptoms similar to those of men, which can lead to pelvic inflammation, lower abdominal pain, fallout, etc., and seriously affect reproductive health.
III. MEDICAL ADMINISTRATION
(i) Antibiotic treatment
1. Large ringed ester antibiotics
In the case of pneumococytal infections, the pre-optimal antibiotics of the Great Cyrethroids are the preferred. Commonly used drugs, such as Archiccin, have a broad antibacterial spectrum and have a strong inhibitive effect on secondary bodies. Achicillin is commonly used for oral or intravenous dripping, with a long half-life in the body and a high drug concentration in the area of infection. Generally, for patients infected with mild pneumonia, oral Achmycin can be used for a given course of treatment, which can be used for a period of two to three consecutive sessions, such as a three-day break for three days. For patients with a more serious condition, an IV can be injected with Achmycin before it is stabilized and converted to oral sequence.
Carcinin is also an antibiotic of the Great Ringed Istitudinal, which can be used for patients with accecin resistance or who do not apply it. However, their gastrointestinal response, such as nausea, vomiting and abdominal pain, is relatively high, and their use requires close attention to patient tolerance.
2. Antibiotics of quinone
Antibiotics of quinone are more effective in the case of urogens, especially in the case of cytogens. Common drugs such as Left Oxygen and Moxysar. The high concentrations of left oxyflour in urology tissue effectively inhibits the growth and reproduction of the terraform. The general method is oral and the procedure is determined by the severity of the condition, usually 7 – 14 days. The antibacterial activity of Mosisa is stronger and may have a better effect on some complex urinary urogenesis, but attention should be paid to possible adverse effects such as central nervous system symptoms (vertebrates, headaches, etc.) and cardiac toxicity (extensions between QTs), so that patients with related underlying diseases should be treated with caution.
3. Tetracyclic antibiotics
Dosicycline is a drug commonly used in the treatment of secondary infections in tetracyclic antibiotics, especially for urinary-genital secondary infections. It can act as an antibacterial by inhibiting the synthesis of proteomics in the trigen. Dossi cycline is administered orally, usually two doses per day for adults of 100 mg per day, with regard to the gastrointestinal reaction, photo-sensitivity, etc. that may occur, during which the patient is informed of sun-proofing measures and the timely adjustment of treatment programmes with adverse reactions.
(ii) Treatment drugs
1. Heating treatment
Physical cooling, such as the use of warm water to wipe the head, armpits, groin, etc., can be used first if the body temperature is below 38.5 °C in case of heat symptoms in patients with secondary infections. Antithermal analgesics, such as brophen, acetylaminophenol etc. may be used if body temperature exceeds 38.5°C. Broven acts as a dethermal decomposition by inhibiting the hypothalamus temperature-recomposition centre, usually repeated every 4 – 6 hours, with attention to dose limits and avoiding adverse effects from excessive use, such as gastrointestinal haemorrhage. Acetylaminophenol is also a commonly used aphthalmic drug, which is relatively mild, but may cause liver damage as a result of excessive use and is therefore strictly used in accordance with instructions or medical instructions.
Cough management
In the case of cough caused by secondary infections, especially irritating dry cough, an anticussis drug can be used. The right methadone is a commonly used central accelerant, which acts as an accelerator by inhibiting the heart of myctic cough, with relatively small side effects, which are applied to people who are dry and coughless. If the cough is accompanied by more glucose, it can be used with gills such as ammonium bromine, which can contribute to respiratory mucous glands and reduce mucous glucosis, thus reducing the mucousity of the glucose and facilitating the excretion of the glucose, which can help to mitigate cough symptoms.
IV. The treatment process and attention to Western medicine
(i) Treatment process
Respiratory systolic infections typically require a 2-3 week treatment process, using antibiotics to ensure that sufficient treatment is available to completely remove the systolic body and prevent recurrence. In the case of urinary genital hysteria infections, the course of treatment is usually 1-2 weeks, but if other complications, such as prostate and pelvic inflammation, are combined, an appropriate extension of the course of treatment may take 3-4 weeks or more, with periodic review and adjustment of the treatment programme to the results of the review.
(ii) Attention
1. Drug resistance monitoring
In the course of treatment, care should be taken with regard to the resistance of secondary bodies. With the widespread use of antibiotics, there has been an increase in the resistance of the systodes. If there is no significant improvement in the patient ‘ s condition during the treatment or if the patient ‘ s condition is repeated, consideration should be given to the existence of resistance problems, the systolic sensibilities test should be conducted in a timely manner and the antibiotics type adjusted.
2. Monitoring of adverse effects
The adverse reactions of patients are closely monitored when various drugs are used. In the case of allergies, gastrointestinal reaction, damage to liver and kidney function, use of antithermal analgesics, possible gastrointestinal haemorrhage, liver damage, possible dizziness, sleep addiction, etc. In case of adverse effects, appropriate measures, such as detoxification, substitution or treatment, are taken in a timely manner.
3. Patient education
The patient and his/her family are informed of the relevant knowledge of secondary infection, including the means of transmission of the disease (e.g. respiratory foam transmission, sexual contact transmission, etc.), the importance of treatment and the requirements of treatment. Patients are instructed to rest during treatment and to maintain good personal hygiene practices, such as hand washing and indoor air circulation. In the case of urinary urology, the patient is informed to avoid sexual activity during the treatment, and the partner should at the same time examine and treat the symptoms to prevent cross-infection.
Conclusions
Western medicine has a clear treatment programme and drug choice in the treatment of secondary infections. Through the rational use of antibiotics, treatment of symptoms, and attention to treatment procedures and related care, it is possible to effectively control secondary infections, mitigate symptoms, improve the quality of life of patients and reduce the occurrence of complications. At the same time, as medical research continues to develop, treatment of secondary infections also needs to be continuously optimized and improved to respond to increasingly complex drug resistance issues and to better meet the treatment needs of patients.
